Various miRNAs have been reported to target members of the Ras/ERK pathway [26] and dysregulation of those miRNAs in cancer cells most likely contributes to tumorigenesis by causing aberrant activation of the Ras/ERK pathway. This evidence concerns the gene MAPK1 and cancer.